Prellis Biologics
Latest round
- Series C
Last raised
- Mar 2025
Total raised
- $47M
Investors
- 9
About Prellis Biologics
Prellis Biologics, Inc.Founded in 2016 and headquartered in San Francisco, US, Prellis Biologics specializes in developing proprietary antibody discovery technologies. Melanie M.Prellis Biologics specializes in advanced antibody discovery technologies through its proprietary EXIS™ platform, which leverages machine learning alongside 3D bioprinted lymph node organoids. This technology enables the rapid and scalable identification of fully human antibodies, which are designed for therapeutic use against various diseases.Prellis Biologics generates revenue through partnerships and collaborations with leading biotech and pharmaceutical companies, typically structured around licensing agreements and collaborative research deals. Clients pay upfront fees, milestone payments, and royalties on future product sales, allowing them to utilize Prellis' technologies in their development processes. The company aims to penetrate new markets, particularly targeting European regions by 2024, to meet the growing demand for innovative drug discovery solutions.
Who invested in Prellis Biologics
9 investors across 7 rounds
See all investors in Prellis Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Mar 10, 2025
Amount
Undisclosed
Investors
Series C
Jun 22, 2022
Amount
$17M
Investors
Series B
Jul 1, 2021
Amount
$19M
Investors
Series A
Mar 12, 2019
Amount
$8.7M
Investors
Seed
Jun 22, 2017
Amount
$1.9M
Investors
Seed
Apr 27, 2017
Amount
Undisclosed
Investors
Seed
Apr 19, 2017
Amount
$0.1M
Investors
Questions about Prellis Biologics
Who invested in Prellis Biologics?
Prellis Biologics has 9 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prellis Biologics raised?
Prellis Biologics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Prellis Biologics last raise money?
Prellis Biologics's most recent round on record is a Series C, in Mar 2025.
What does Prellis Biologics do?
Prellis Biologics is a biotechnology company.
Where is Prellis Biologics headquartered?
Prellis Biologics is headquartered in San Francisco, US.
Which VCs invest in companies like Prellis Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Prellis Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Prellis Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.